These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 29277956)

  • 1. Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney.
    Shelton BA; Sawinski D; Mehta S; Reed RD; MacLennan PA; Locke JE
    Transpl Infect Dis; 2018 Apr; 20(2):e12829. PubMed ID: 29277956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Willingness to Accept Hepatitis C Seropositive Kidneys Among Hepatitis C RNA-Positive Waitlisted Patients.
    Sageshima J; Troppmann C; McVicar JP; Santhanakrishnan C; de Mattos AM; Perez RV
    Transplantation; 2018 Jul; 102(7):1179-1187. PubMed ID: 29953423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Benefit of Transplantation with a Deceased Diabetic Donor Kidney Compared with Remaining on the Waitlist.
    Cohen JB; Eddinger KC; Locke JE; Forde KA; Reese PP; Sawinski DL
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):974-982. PubMed ID: 28546439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.
    Sawinski D; Forde KA; Lo Re V; Goldberg DS; Cohen JB; Locke JE; Bloom RD; Brensinger C; Weldon J; Shults J; Reese PP
    Am J Kidney Dis; 2019 Jun; 73(6):815-826. PubMed ID: 30704882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients.
    Kucirka LM; Peters TG; Segev DL
    Am J Kidney Dis; 2012 Jul; 60(1):112-20. PubMed ID: 22560841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.
    Bowring MG; Kucirka LM; Massie AB; Ishaque T; Bae S; Shaffer AA; Garonzik Wang J; Sulkowski M; Desai N; Segev DL; Durand CM
    Transplantation; 2018 Dec; 102(12):2088-2095. PubMed ID: 29912046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of using hepatitis c virus nucleic acid test-positive donor hearts on heart transplant waitlist time and transplant rate.
    Gernhofer YK; Brambatti M; Greenberg BH; Adler E; Aslam S; Pretorius V
    J Heart Lung Transplant; 2019 Nov; 38(11):1178-1188. PubMed ID: 31492607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients.
    Kadatz M; Klarenbach S; Gill J; Gill JS
    Am J Transplant; 2018 Oct; 18(10):2457-2464. PubMed ID: 29797402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Hepatitis C Positive Organs: Patient Attitudes in Urban Chicago.
    Couri T; Cotter TG; Chen D; Hammes M; Reddy B; Josephson M; Yeh H; Chung RT; Paul S
    Am J Nephrol; 2019; 49(1):32-40. PubMed ID: 30554209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring patient willingness to accept hepatitis C-infected kidneys for transplantation.
    Edwards GC; Shipe ME; Smith L; Gamble C; Shaffer D; Concepcion BP; Forbes R
    BMC Nephrol; 2020 Nov; 21(1):473. PubMed ID: 33172408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in donor organ offer acceptance and lung transplantation survival.
    Mulvihill MS; Lee HJ; Weber J; Choi AY; Cox ML; Yerokun BA; Bishawi MA; Klapper J; Kuchibhatla M; Hartwig MG
    J Heart Lung Transplant; 2020 Apr; 39(4):353-362. PubMed ID: 32029400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider Attitudes toward the Use of Hepatitis C Virus-Positive Organs in Kidney Transplantation.
    Couri T; Katz J; Stoeckle K; Nugooru A; Yeh H; Chung R; Paul S
    Am J Nephrol; 2019; 50(3):168-176. PubMed ID: 31390615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Benefit in Older Patients Associated With Earlier Transplant With High KDPI Kidneys.
    Jay CL; Washburn K; Dean PG; Helmick RA; Pugh JA; Stegall MD
    Transplantation; 2017 Apr; 101(4):867-872. PubMed ID: 27495758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Process of selecting and educating HCV-uninfected kidney waiting-list candidates for HCV-infected kidney transplantation.
    Sise ME; Wojciechowski D; Chute DF; Gustafson J; Chung RT; Williams WW; Elias N
    Artif Organs; 2019 Sep; 43(9):913-920. PubMed ID: 31001828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts.
    Scalea JR; Barth RN; Munivenkatappa R; Philosophe B; Cooper M; Whitlow V; LaMattina JC
    Transplantation; 2015 Jun; 99(6):1192-6. PubMed ID: 25340605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To decline or not to decline: Consequences of decision-making regarding lung offers from donors with hepatitis C.
    Ruck JM; Bowring MG; Durand CM; Ha JS; Massie AB; Segev DL; Merlo CA; Bush EL
    J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1967-1976.e2. PubMed ID: 37678605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation.
    Shelton BA; Sawinski D; Linas BP; Reese PP; Mustian M; Hungerpiller M; Reed RD; MacLennan PA; Locke JE
    Am J Transplant; 2018 Oct; 18(10):2483-2495. PubMed ID: 30058218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to Kidney Transplantation among HIV-Infected Waitlist Candidates.
    Locke JE; Mehta S; Sawinski D; Gustafson S; Shelton BA; Reed RD; MacLennan P; Bolch C; Durand C; Massie A; Mannon RB; Gaston R; Saag M; Overton T; Segev DL
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):467-475. PubMed ID: 28232406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional independence, access to kidney transplantation and waitlist mortality.
    Chu NM; Sison S; Muzaale AD; Haugen CE; Garonzik-Wang JM; Brennan DC; Norman SP; Segev DL; McAdams-DeMarco M
    Nephrol Dial Transplant; 2020 May; 35(5):870-877. PubMed ID: 31860087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus-infected kidney waitlist patients: Treat now or treat later?
    Kiberd BA; Doucette K; Vinson AJ; Tennankore KK
    Am J Transplant; 2018 Oct; 18(10):2443-2450. PubMed ID: 29687948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.